TrialAmerican journal of clinical dermatology2024

Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies.

Lawrence F Eichenfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.